Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Oxford Nanopore Technologies PLC ( (GB:ONT) ) has provided an update.
Oxford Nanopore Technologies has issued 190,696 new ordinary shares following the exercise of employee share options and the operation of certain remuneration schemes, with the new shares admitted to the FCA’s Official List and to trading on the London Stock Exchange’s main market under the company’s existing block listing facility. Following this allotment, Oxford Nanopore’s issued share capital stands at 966,057,025 ordinary shares with no treasury shares held, establishing the updated total voting rights figure that shareholders must use to assess disclosure thresholds under UK transparency rules and leaving headroom for the admission of a further 6,468,179 shares under the current block listing.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £1.70 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Spark’s Take on GB:ONT Stock
According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.
The overall stock score of 51 reflects a combination of financial challenges and technical weaknesses, offset by positive earnings guidance and corporate governance initiatives. The company’s revenue growth and strategic focus on improving profitability are promising, but current financial and market conditions pose significant risks.
To see Spark’s full report on GB:ONT stock, click here.
More about Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies plc is a UK-listed company operating in the life sciences and genomics sector, focused on developing and commercialising nanopore-based DNA and RNA sequencing technologies. Its products are used by researchers and commercial customers globally for applications including genomics research, clinical and diagnostic development, and other data-rich biological analyses.
Average Trading Volume: 1,734,767
Technical Sentiment Signal: Strong Sell
Current Market Cap: £1.24B
For a thorough assessment of ONT stock, go to TipRanks’ Stock Analysis page.